Ebos Group Limited · NZX:EBO
Ebos — Macquarie Australia Conference 2024
31 slides from Ebos's conference presentation, May 7, 2024
Slide 1: Macquarie Australia Conference Presentation
7 May 2024 NZX/ASX Code: EBO Macquarie Australia Conference Presentation Please see attached a copy of a presentation to be delivered at the Macquarie Australia Conference today. For personal use only For further information please contact: Martin Krauskopf Executive General Manager, Strategy and M&
Slide 2: Investor Presentation - Macquarie Australia Conference
For personal use only INVESTOR PRESENTATION MACQUARIE AUSTRALIA CONFERENCE 7 May 2024
Slide 3: Disclaimer
DISCLAIMER The information in this presentation was prepared by EBOS Group Limited (“EBOS” or the “Group”) with due care and attention. However, the information is supplied in summary form and is therefore not necessarily complete, and, to the extent permitted by law, no representation is made as to
Slide 4: Group Overview
For personal use only 3 GROUP OVERVIEW
Slide 5: EBOS Snapshot
EBOS SNAPSHOT EBOS Group is a leading diversified Healthcare and Animal Care group For personal use only Snapshot: Primary businesses: Segments3: Community Pharmacy ~$6bn - Pharmacy wholesale 12% Community Pharmacy market capitalisation1 - TerryWhite Chemmart 10% Institutional Healthcare Healthcare
Slide 6: Investment Themes
INVESTMENT THEMES EBOS has had a strong track record of growth, yield and shareholder returns For personal use only Defensive growth sectors Scale and leading positions Diversified group Multiple growth drivers Strong financial track record 5
Slide 7: Multiple Growth Drivers
MULTIPLE GROWTH DRIVERS EBOS leverages multiple growth drivers across its businesses For personal use only Key growth businesses Key growth drivers Pharmacy Wholesale TerryWhite Chemmart Investing for growth Organic growth Medical Consumables Medical Technology Distribution Distribution Contract Log
Slide 8: Strategic Acquisitions
STRATEGIC ACQUISITIONS Acquisitions diversify and grow our earnings and are value accretive to shareholders For personal use only Acquisition objectives Target profile 1. Strengthen our core businesses ✓ Targets: established, profitable, growing and well managed businesses 2. Extend existing busines
Slide 9: Strong Financial Track Record
STRONG FINANCIAL TRACK RECORD EBOS has delivered consistent financial performance over the long term Underlying EBITDA1,2: Underlying EPS1,2: For personal use only (A$m) (A$ cents per share) Shareholder returns3: 15.6% CAGR2 10.7% CAGR2 28% 3 year TSR F F F F F F F F F F F F F F F F F F F F Return o
Slide 10: H1 FY24 Summary Results
H1 FY24 SUMMARY RESULTS EBOS achieved strong growth reflecting the benefits of its diversified portfolio For personal use only $m Underlying Var Statutory Var Revenue 6,582.5 7.1% 6,582.5 7.1% EBITDA 313.2 8.3% 303.1 4.8% EBIT 259.9 8.5% 236.7 4.7% Net Profit After Tax 152.4 7.6% 136.2
Slide 11: Near-Term Growth Strategy
NEAR-TERM GROWTH STRATEGY We are making strong progress on the key focus areas of our near-term strategy to increase earnings For personal use only M&A Cost reduction initiatives New Community Pharmacy revenue opportunities Base business growth EBOS’ earnings excluding Positive traction with new Sup
Slide 12: Diverse and Well Established Growth Strategies
DIVERSE AND WELL ESTABLISHED GROWTH STRATEGIES EBOS has multiple organic and inorganic growth drivers across the Group that are well established For personal use only Division Organic Capex M&A Community • Continue to build on positive traction with new and • Continue to realise the benefits of our
Slide 13: Sustainability Snapshot
SUSTAINABILITY SNAPSHOT For personal use only 1 Notes 12 1. Achievement of net zero Scope 1 emissions relates to our Australian and New Zealand operations.
Slide 14: Division Update - Healthcare
For personal use only DIVISION UPDATE – HEALTHCARE 13
Slide 15: Industry Trends - Healthcare (Australia)
INDUSTRY TRENDS – HEALTHCARE (AUSTRALIA) The growing and ageing population continues to provide a structural tailwind For personal use only Projected Australian population (m)1 Australian health expenditure1 PBS funding2 65+ age group expected to grow > 2x the 65+ age group are ~17% of the populatio
Slide 16: Community Pharmacy Wholesale
COMMUNITY PHARMACY WHOLESALE For personal use only Business description: Drivers and dynamics: • A leading pharmaceutical wholesaler in Australia and New Zealand Alignment to large and fast growing pharmacy brands • ~30% share in Australian ethical wholesaling segment1 and ~50% in 1 and banner group
Slide 17: TerryWhite Chemmart
TERRYWHITE CHEMMART For personal use only Business description: Drivers and dynamics: • One of Australia’s leading community pharmacy networks with store numbers approaching 600 1 Ongoing expansion of the TWC network • Focus on health advice and differentiated service • EBOS is the franchisor and wh
Slide 18: Institutional Healthcare (ex. Medical Technology)
INSTITUTIONAL HEALTHCARE (EX. MEDICAL TECHNOLOGY) For personal use only Business description: Drivers and dynamics: • A leading distributor and wholesaler of hospital medicines and medical consumables 1 Exposure to specialty medicines, a higher growth market • Trusted, long-term partner to hospitals
Slide 19: Medical Technology
MEDICAL TECHNOLOGY For personal use only Business description: Drivers and dynamics: • A leading independent distributor of medical devices, consumables and equipment in Asia Pacific with significant presence in several Ageing population in developed markets and increasing therapeutic areas 1 wealth
Slide 20: Southeast Asia Strategy
SOUTHEAST ASIA STRATEGY EBOS MedTech’s Asia Pacific presence provides a unique offering to global OEMs looking to access the region For personal use only Attractive dynamics of Southeast Asia The long-term potential of Southeast Asia Growth strategy • Large population with growing wealth and healthc
Slide 21: Contract Logistics
CONTRACT LOGISTICS For personal use only Business description: Drivers and dynamics: • Specialised healthcare contract logistics provider in Australia and New Zealand 1 Opportunity to grow share in Australia and New Zealand • Trusted partner for pharmaceutical manufacturers • World class facilities
Slide 22: Division Update - Animal Care
For personal use only DIVISION UPDATE – ANIMAL CARE 21
Slide 23: Industry Trends - Animal Care
INDUSTRY TRENDS – ANIMAL CARE The industry has seen considerable growth, driven by increased pet ownership, humanisation of pets and product premiumisation For personal use only Pet population in Australia has grown (millions) Proportion of pet owning households has increased 11.7 +32% 8.9 5.3 +42%
Slide 24: Animal Care
ANIMAL CARE For personal use only Business description: Drivers and dynamics: • A leading owner, marketer and distributor of animal care brands Premium food category has grown whilst discretionary • Provide quality nutrition and wellbeing for pets through: 1 categories have traded softly in current
Slide 25: New Product Development
NEW PRODUCT DEVELOPMENT Core product competencies Recent new products to market and category expansion For personal use only Dry adult dog food Black Hawk Healthy Benefits Black Hawk cat food extension Dog treats Vitapet food – grocery Superior dog rolls and treats Existing branded portfolio generat
Slide 26: Conclusion
For personal use only 25 CONCLUSION
Slide 27: Conclusion
CONCLUSION EBOS has had a strong track record of growth, yield and shareholder returns For personal use only Defensive growth sectors Scale and leading positions Diversified group Multiple growth drivers Strong financial track record 26
Slide 28: Questions
For personal use only Questions
Slide 29: Appendix
For personal use only 28 APPENDIX
Slide 30: Glossary of Terms and Measures
GLOSSARY OF TERMS AND MEASURES Except where noted, common terms and measures used in this document are based upon the following definitions: Term Definition For personal use only Revenue Revenue from the sale of goods and the rendering of services. Gross Operating Revenue (GOR) Revenue less cost of
Slide 31: www.ebosgroup.com
For personal use only www.ebosgroup.com